Headlines
-
2022 PATY state winners announced
Monday | Aug 29 2022HIBISCUS Day and Night Pharmacy's Jessie Chen will be seeking to secure the Northern Territory's third successive Pharmacy Guild of Australia/Maxigesic Pharmacy Assistant of the Year (PATY) Award, after claiming the Territory title.
-
No consent no vaccine
Monday | Aug 29 2022A FORMER Jetstar employee who was dismissed by the airline for not being immunised against COVID-19 attempted to get a pharmacist to sign a document acknowledging that she did not consent to being vaccinated.
-
Positive outlook for MDR
Friday | Aug 26 2022MEDTECH firm, MedAdvisor (MDR), plans to use its relationship with major shareholder, the Pharmacy Guild of Australia (PD 27 Jul), to boost revenues going forward.
-
API integration pleasing
Friday | Aug 26 2022RETAIL conglomerate, Wesfarmers, is eyeing opportunities to strengthen its Health division, after reporting a $25 million loss for the three months to 30 Jun.
-
Pharmacies must meet expectations
Thursday | Aug 25 2022REGARDLESS of what business model pharmacy owners adopt it is crucial that their offering meets patients' expectations, Pharmacy Guild of Australia National President, Trent Twomey, believes.
-
Tenecteplase shortage
Thursday | Aug 25 2022THE shelf-life of batches of Boehringer Ingelheim's (BI's)thrombolysis treatment, Metalyse (tenecteplase) are being extended by 12 months in response to global supply shortages of the medication.
-
Pharmacy spending on the rise
Wednesday | Aug 24 2022TOTAL consumer spending in community pharmacy has grown by 21.4% since Jul 2019, with the average basket spend now $35.80, new data from Westpac and the Pharmacy Guild of Australia reveals.
-
No delay to NQPSPP launch: Owen
Wednesday | Aug 24 2022SUGGESTIONS that the start date for the North Queensland Pharmacy Scope of Practice Pilot (NQPSPP) is being delayed are wide of the mark, Pharmacy Guild of Australia Queensland Branch President, Chris Owen, says.
-
NMP 2022 consultation underway
Tuesday | Aug 23 2022STAKEHOLDERS have until 27 Sep to provide feedback on the revised draft of the 2022 National Medicines Policy (NMP) Review.
-
TGA acts on naloxone shortage
Tuesday | Aug 23 2022THE Therapeutic Goods Administration (TGA) has granted Section 19A approval to authorise Mundipharma to import and supply Nyxoid naloxone 1.8mg nasal spray from the UK, to address shortages in Australia.